Local drug delivery in recurrent malignant gliomas

In recurrent malignant gliomas, we scheduled a protocol by adding to systemic temozolomide a local treatment delivered through a reservoire positioned in the surgically created cavity, consisting of either mitoxantrone, liposome-loaded doxorubicine or nimustine (ACNU). The progression-free survival...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Neurological sciences 2005-05, Vol.26 Suppl 1 (S1), p.S37-s39
Hauptverfasser:	Boiardi, A, Eoli, M, Salmaggi, A, Lamperti, E, Botturi, A, Solari, A, Di Meco, F, Broggi, G, Silvani, A
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Brain Neoplasms - drug therapy Brain Neoplasms - mortality Doxorubicin - administration & dosage Doxorubicin - therapeutic use Drug Delivery Systems - methods Drug Therapy, Combination Female Follow-Up Studies Glioma - drug therapy Glioma - mortality Humans Male Middle Aged Neoplasm Recurrence, Local - drug therapy Neurology Neurosciences Nimustine - administration & dosage Nimustine - therapeutic use Survival Rate Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!